Royalty Pharma PLCNASDAQ:RPRX
- LAST PRICE28.2100
- TODAY'S CHANGE (%)0.1400 (0.4988%)
- Bid / Lots27.5800/ 1
- Ask / Lots28.4000/ 5
- Open / Previous Close28.2200 / 28.0700
- Day Range
- 52 Week Range
- Volume1,897,985
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
- TSX Comp
- TSX Venture
- DJIA
- S&P 500
- NASDAQ
| Time | Volume | RPRX |
|---|---|---|
| 09:32 ET | 18616 | 28.25 |
| 09:34 ET | 2288 | 28.23 |
| 09:36 ET | 2750 | 28.23 |
| 09:38 ET | 3467 | 28.23 |
| 09:39 ET | 104086 | 28.23 |
| 09:41 ET | 8265 | 28.24 |
| 09:43 ET | 4246 | 28.27 |
| 09:45 ET | 20969 | 28.29 |
| 09:48 ET | 3971 | 28.25 |
| 09:50 ET | 9829 | 28.24 |
| 09:52 ET | 2151 | 28.28 |
| 09:54 ET | 2800 | 28.25 |
| 09:56 ET | 9011 | 28.15 |
| 09:57 ET | 23205 | 28.19 |
| 09:59 ET | 200 | 28.19 |
| 10:01 ET | 5474 | 28.16 |
| 10:03 ET | 2970 | 28.135 |
| 10:06 ET | 1435 | 28.15 |
| 10:08 ET | 10932 | 28.135 |
| 10:10 ET | 3761 | 28.15 |
| 10:12 ET | 1047 | 28.17 |
| 10:14 ET | 2864 | 28.185 |
| 10:15 ET | 3161 | 28.135 |
| 10:17 ET | 1874 | 28.12 |
| 10:19 ET | 700 | 28.12 |
| 10:21 ET | 500 | 28.115 |
| 10:24 ET | 1379 | 28.135 |
| 10:26 ET | 2547 | 28.125 |
| 10:28 ET | 6287 | 28.145 |
| 10:30 ET | 500 | 28.155 |
| 10:32 ET | 200 | 28.179 |
| 10:33 ET | 2497 | 28.1725 |
| 10:35 ET | 7717 | 28.225 |
| 10:37 ET | 2549 | 28.285 |
| 10:39 ET | 4045 | 28.29 |
| 10:42 ET | 3516 | 28.26 |
| 10:44 ET | 2042 | 28.265 |
| 10:46 ET | 674 | 28.27 |
| 10:48 ET | 1472 | 28.27 |
| 10:50 ET | 2828 | 28.275 |
| 10:51 ET | 2985 | 28.26 |
| 10:53 ET | 1696 | 28.24 |
| 10:55 ET | 2777 | 28.265 |
| 10:57 ET | 7367 | 28.275 |
| 11:00 ET | 1200 | 28.285 |
| 11:02 ET | 2033 | 28.32 |
| 11:04 ET | 12052 | 28.3 |
| 11:06 ET | 112816 | 28.27 |
| 11:08 ET | 10325 | 28.265 |
| 11:09 ET | 3653 | 28.27 |
| 11:11 ET | 3800 | 28.3 |
| 11:13 ET | 3288 | 28.3 |
| 11:15 ET | 3853 | 28.31 |
| 11:18 ET | 4537 | 28.34 |
| 11:20 ET | 3374 | 28.36 |
| 11:22 ET | 2466 | 28.32 |
| 11:24 ET | 1542 | 28.325 |
| 11:26 ET | 4409 | 28.34 |
| 11:27 ET | 1818 | 28.34 |
| 11:29 ET | 3017 | 28.34 |
| 11:31 ET | 1300 | 28.35 |
| 11:33 ET | 2340 | 28.345 |
| 11:36 ET | 43965 | 28.37 |
| 11:38 ET | 2256 | 28.36 |
| 11:40 ET | 7128 | 28.315 |
| 11:42 ET | 3191 | 28.31 |
| 11:44 ET | 3413 | 28.31 |
| 11:45 ET | 2326 | 28.315 |
| 11:47 ET | 931 | 28.305 |
| 11:49 ET | 5095 | 28.28 |
| 11:51 ET | 301 | 28.28 |
| 11:54 ET | 2870 | 28.2954 |
| 11:56 ET | 4321 | 28.3363 |
| 11:58 ET | 719 | 28.33 |
| 12:00 ET | 879 | 28.345 |
| 12:02 ET | 11821 | 28.325 |
| 12:03 ET | 2107 | 28.32 |
| 12:05 ET | 6169 | 28.295 |
| 12:07 ET | 2419 | 28.29 |
| 12:09 ET | 1201 | 28.31 |
| 12:12 ET | 6906 | 28.31 |
| 12:14 ET | 2871 | 28.3 |
| 12:16 ET | 3222 | 28.305 |
| 12:18 ET | 5777 | 28.315 |
| 12:20 ET | 1607 | 28.305 |
| 12:21 ET | 1300 | 28.305 |
| 12:23 ET | 15607 | 28.34 |
| 12:25 ET | 2467 | 28.34 |
| 12:27 ET | 3250 | 28.34 |
| 12:30 ET | 5152 | 28.295 |
| 12:32 ET | 2194 | 28.265 |
| 12:34 ET | 5573 | 28.28 |
| 12:36 ET | 900 | 28.275 |
| 12:38 ET | 5054 | 28.295 |
| 12:39 ET | 300 | 28.2945 |
| 12:41 ET | 3965 | 28.295 |
| 12:43 ET | 3122 | 28.305 |
| 12:45 ET | 5027 | 28.29 |
| 12:48 ET | 6497 | 28.3 |
| 12:50 ET | 3420 | 28.305 |
| 12:54 ET | 3400 | 28.32 |
| 12:56 ET | 3289 | 28.315 |
| 12:57 ET | 853 | 28.32 |
| 12:59 ET | 4503 | 28.315 |
| 01:01 ET | 2663 | 28.295 |
| 01:03 ET | 4008 | 28.28 |
| 01:06 ET | 5335 | 28.29 |
| 01:08 ET | 6134 | 28.315 |
| 01:10 ET | 4780 | 28.3034 |
| 01:12 ET | 154 | 28.305 |
| 01:14 ET | 3841 | 28.315 |
| 01:15 ET | 3882 | 28.295 |
| 01:17 ET | 3126 | 28.2958 |
| 01:19 ET | 5254 | 28.31 |
| 01:21 ET | 492 | 28.3012 |
| 01:24 ET | 3624 | 28.3 |
| 01:26 ET | 287 | 28.3 |
| 01:28 ET | 4288 | 28.31 |
| 01:30 ET | 4391 | 28.295 |
| 01:32 ET | 1946 | 28.305 |
| 01:33 ET | 5561 | 28.305 |
| 01:35 ET | 2102 | 28.29 |
| 01:37 ET | 2854 | 28.27 |
| 01:39 ET | 12414 | 28.235 |
| 01:42 ET | 1783 | 28.225 |
| 01:44 ET | 4498 | 28.23 |
| 01:46 ET | 200 | 28.2301 |
| 01:48 ET | 3049 | 28.2499 |
| 01:50 ET | 3129 | 28.23 |
| 01:51 ET | 2518 | 28.235 |
| 01:53 ET | 4131 | 28.26 |
| 01:55 ET | 3715 | 28.25 |
| 01:57 ET | 6226 | 28.255 |
| 02:00 ET | 1163 | 28.27 |
| 02:02 ET | 2612 | 28.255 |
| 02:04 ET | 1300 | 28.265 |
| 02:06 ET | 2458 | 28.25 |
| 02:08 ET | 543 | 28.2505 |
| 02:09 ET | 7805 | 28.23 |
| 02:11 ET | 2291 | 28.245 |
| 02:13 ET | 900 | 28.24 |
| 02:15 ET | 454 | 28.245 |
| 02:18 ET | 8265 | 28.225 |
| 02:20 ET | 3307 | 28.22 |
| 02:22 ET | 3119 | 28.21 |
| 02:24 ET | 2019 | 28.215 |
| 02:26 ET | 1203 | 28.22 |
| 02:27 ET | 571 | 28.225 |
| 02:29 ET | 1100 | 28.245 |
| 02:31 ET | 500 | 28.25 |
| 02:33 ET | 12021 | 28.21 |
| 02:36 ET | 1297 | 28.205 |
| 02:38 ET | 585 | 28.21 |
| 02:40 ET | 300 | 28.205 |
| 02:42 ET | 4900 | 28.21 |
| 02:44 ET | 4419 | 28.2 |
| 02:45 ET | 631 | 28.195 |
| 02:47 ET | 317 | 28.2 |
| 02:49 ET | 2146 | 28.205 |
| 02:51 ET | 697 | 28.21 |
| 02:54 ET | 4609 | 28.235 |
| 02:56 ET | 9918 | 28.23 |
| 02:58 ET | 563 | 28.23 |
| 03:00 ET | 900 | 28.24 |
| 03:02 ET | 5858 | 28.23 |
| 03:03 ET | 1663 | 28.225 |
| 03:05 ET | 2422 | 28.235 |
| 03:07 ET | 6787 | 28.22 |
| 03:09 ET | 6603 | 28.245 |
| 03:12 ET | 1863 | 28.245 |
| 03:14 ET | 566 | 28.245 |
| 03:16 ET | 11189 | 28.225 |
| 03:18 ET | 16587 | 28.195 |
| 03:20 ET | 2379 | 28.185 |
| 03:21 ET | 8942 | 28.175 |
| 03:23 ET | 1568 | 28.175 |
| 03:25 ET | 2060 | 28.165 |
| 03:27 ET | 918 | 28.165 |
| 03:30 ET | 12632 | 28.125 |
| 03:32 ET | 5607 | 28.135 |
| 03:34 ET | 1559 | 28.14 |
| 03:36 ET | 8414 | 28.115 |
| 03:38 ET | 7677 | 28.145 |
| 03:39 ET | 2199 | 28.14 |
| 03:41 ET | 3605 | 28.155 |
| 03:43 ET | 6885 | 28.145 |
| 03:45 ET | 8741 | 28.135 |
| 03:48 ET | 15026 | 28.195 |
| 03:50 ET | 8487 | 28.19 |
| 03:52 ET | 4829 | 28.205 |
| 03:54 ET | 38712 | 28.165 |
| 03:56 ET | 34551 | 28.205 |
| 03:57 ET | 35756 | 28.22 |
| 03:59 ET | 40976 | 28.21 |
May 13, 2024
Royalty Pharma to Present at Upcoming Investor Conferences, from 8:15AM ET on Monday May 13, 2024 by Dow Jones
8:15AM ET on Monday May 13, 2024 by Dow Jones
May 9, 2024
Royalty Pharma Reports First Quarter 2024 Results, from 7:00AM ET on Thursday May 09, 2024 by Dow Jones
7:00AM ET on Thursday May 09, 2024 by Dow Jones*DJ Royalty Pharma 1Q Net $5M >RPRX, from 7:00AM ET on Thursday May 09, 2024 by Dow Jones
7:00AM ET on Thursday May 09, 2024 by Dow JonesRoyalty Pharma to Acquire Royalty Interest in Sanofi's Frexalimab, from 6:45AM ET on Thursday May 09, 2024 by Dow Jones
6:45AM ET on Thursday May 09, 2024 by Dow JonesPress Release: Royalty Pharma to Acquire Royalty Interest in Sanofi's Frexalimab, from 6:45AM ET on Thursday May 09, 2024 by Dow Jones
6:45AM ET on Thursday May 09, 2024 by Dow Jones
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
Royalty Pharma PLC | 16.8B | 15.8x | +1.83% |
Amneal Pharmaceuticals Inc | 2.1B | -12.2x | --- |
Catalent Inc | 10.0B | -8.6x | --- |
Jazz Pharmaceuticals PLC | 7.1B | 22.6x | -3.53% |
Mallinckrodt PLC | 1.6M | 0.0x | --- |
Prestige Consumer Healthcare Inc | 3.5B | -40.5x | --- |
Company Information
Royalty Pharma plc is a buyer of biopharmaceutical royalties and a funder of innovation across the biopharmaceutical industry. The Company collaborates with innovators from academic institutions, research hospitals and non-profits through small and mid-cap biotechnology companies to global pharmaceutical companies. Its portfolio consists of royalties on over 35 commercial products, including Vertex’s Trikafta, GSK’s Trelegy, Roche’s Evrysdi, Johnson & Johnson’s Tremfya, Biogen’s Tysabri and Spinraza, AbbVie and Johnson & Johnson’s Imbruvica, Astellas and Pfizer’s Xtandi, Novartis’ Promacta, Pfizer’s Nurtec ODT and Gilead’s Trodelvy, and 14 development-stage product candidates. Its development-stage product candidates include Aficamten, Ampreloxetine, BCX10013, MK-8189, Ecopipam, Olpasiran, Pelabresib, KarXT, Pelacarsen, Seltorexant, Trontinemab, TEV-'749, Tulmimetostat and Vanzacaftor. Its subsidiaries include Royalty Pharma Holdings Ltd., Royalty Pharma Investments and others.
Contact Information
- Headquarters
- 110 East 59th StreetNEW YORK, NY, United States 10022
- Phone
- 212-883-0200
- Fax
- ---
Executives
- Chairman of the Board, Chief Executive Officer
- Pablo Legorreta
- Vice Chairman, Executive Vice President
- Christopher Hite
- Chief Financial Officer, Executive Vice President
- Terrance Coyne
- Executive Vice President - Investments and Chief Legal Officer
- George Lloyd
- Executive Vice President - Research and Investments
- Marshall Urist
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $16.8B |
|---|---|
Revenue (TTM) | $2.2B |
Shares Outstanding | 597.4M |
Dividend Yield | 2.98% |
Annual Dividend Rate | 0.8400 USD |
Ex-Dividend Date | 05-16-24 |
Pay Date | 06-14-24 |
Beta | 0.47 |
EPS | $1.78 |
Book Value | $14.61 |
P/E Ratio | 15.8x |
Price/Sales (TTM) | 7.5 |
Price/Cash Flow (TTM) | 14.1x |
Operating Margin | 41.96% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
